BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

466 related articles for article (PubMed ID: 32273252)

  • 1. Protocol for a randomised controlled trial evaluating the impact of a community pharmacy discharge medication reconciliation service on unplanned hospital readmissions - The DCMedsRec trial.
    Duncan G; Ngo C; Fanning L; Taylor DA; McNamara K; Caliph S; Suen B; Johnston S; Darzins P
    Res Social Adm Pharm; 2021 Feb; 17(2):460-465. PubMed ID: 32273252
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Using novel Canadian resources to improve medication reconciliation at discharge: study protocol for a randomized controlled trial.
    Tamblyn R; Huang AR; Meguerditchian AN; Winslade NE; Rochefort C; Forster A; Eguale T; Buckeridge D; Jacques A; Naicker K; Reidel KE
    Trials; 2012 Aug; 13():150. PubMed ID: 22920446
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of a pharmacist-led medication review on hospital readmission in a pediatric and elderly population: study protocol for a randomized open-label controlled trial.
    Renaudin P; Baumstarck K; Daumas A; Esteve MA; Gayet S; Auquier P; Tsimaratos M; Villani P; Honore S
    Trials; 2017 Feb; 18(1):65. PubMed ID: 28183322
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inpatient pharmacists using a readmission risk model in supporting discharge medication reconciliation to reduce unplanned hospital readmissions: a quality improvement intervention.
    Gallagher D; Greenland M; Lindquist D; Sadolf L; Scully C; Knutsen K; Zhao C; Goldstein BA; Burgess L
    BMJ Open Qual; 2022 Mar; 11(1):. PubMed ID: 35241436
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of drug reconciliation at discharge and communication between hospital and community pharmacists on drug-related problems: study protocol for a randomized controlled trial.
    Pourrat X; Roux C; Bouzige B; Garnier V; Develay A; Allenet B; Fraysse M; Halimi JM; Grassin J; Giraudeau B
    Trials; 2014 Jun; 15():260. PubMed ID: 24981605
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacist linkage in care transitions: From academic medical center to community.
    Bloodworth LS; Malinowski SS; Lirette ST; Ross LA
    J Am Pharm Assoc (2003); 2019; 59(6):896-904. PubMed ID: 31590926
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacy-led medication reconciliation programmes at hospital transitions: a systematic review and meta-analysis.
    Mekonnen AB; McLachlan AJ; Brien JA
    J Clin Pharm Ther; 2016 Apr; 41(2):128-44. PubMed ID: 26913812
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of clinical pharmacist engagement in ward teams on the number of drug-related readmissions among older patients with dementia or cognitive impairment: An economic evaluation.
    Sjölander M; Lindholm L; Pfister B; Jonsson J; Schneede J; Lövheim H; Gustafsson M
    Res Social Adm Pharm; 2019 Mar; 15(3):287-291. PubMed ID: 29778344
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of a Collaborative Protocolized Approach by Community Pharmacists and General Medical Practitioners for an Australian Minor Ailments Scheme: Protocol for a Cluster Randomized Controlled Trial.
    Dineen-Griffin S; Garcia-Cardenas V; Rogers K; Williams K; Benrimoj SI
    JMIR Res Protoc; 2019 Aug; 8(8):e13973. PubMed ID: 31400107
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Community pharmacy transition of care services and rural hospital readmissions: A case study.
    Patton AP; Liu Y; Hartwig DM; May JR; Moon J; Stoner SC; Guthrie KD
    J Am Pharm Assoc (2003); 2017; 57(3S):S252-S258.e3. PubMed ID: 28412054
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effectiveness of pharmacist-led medication reconciliation programmes on clinical outcomes at hospital transitions: a systematic review and meta-analysis.
    Mekonnen AB; McLachlan AJ; Brien JA
    BMJ Open; 2016 Feb; 6(2):e010003. PubMed ID: 26908524
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Improving care transitions through medication therapy management: A community partnership to reduce readmissions in multiple health-systems.
    Heaton PC; Frede S; Kordahi A; Lowery L; Moorhead B; Kirby J; Kunze N; Luder H
    J Am Pharm Assoc (2003); 2019; 59(3):319-328. PubMed ID: 30819640
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A role for pharmacists in community-based post-discharge warfarin management: protocol for the 'the role of community pharmacy in post hospital management of patients initiated on warfarin' study.
    Stafford L; Peterson GM; Bereznicki LR; Jackson SL
    BMC Health Serv Res; 2011 Jan; 11():16. PubMed ID: 21261998
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of the population health inpatient Medicare Advantage pharmacist intervention on hospital readmissions: A quasi-experimental controlled study.
    Nguyen AT; Wisniewski J; Leang DW; Keller MS; Rosen S; Shane R; Pevnick JM
    J Manag Care Spec Pharm; 2023 Mar; 29(3):266-275. PubMed ID: 36840959
    [No Abstract]   [Full Text] [Related]  

  • 15. Exploring the association of the discharge medicines review with patient hospital readmissions through national routine data linkage in Wales: a retrospective cohort study.
    Mantzourani E; Nazar H; Phibben C; Pang J; John G; Evans A; Thomas H; Way C; Hodson K
    BMJ Open; 2020 Feb; 10(2):e033551. PubMed ID: 32041857
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of a pharmacist-driven intervention program on hospital readmissions.
    Shull MT; Braitman LE; Stites SD; DeLuca A; Hauser D
    Am J Health Syst Pharm; 2018 May; 75(9):e221-e230. PubMed ID: 29691265
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effectiveness of a multicomponent pharmacist intervention at hospital discharge for drug-related problems: A cluster randomised cross-over trial.
    Pourrat X; Leyrat C; Allenet B; Bouzige B; Develay A; Fraysse M; Garnier V; Halimi JM; Roux-Marson C; Giraudeau B
    Br J Clin Pharmacol; 2020 Dec; 86(12):2441-2454. PubMed ID: 32383801
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of a trAnSitional Pharmacist Intervention in geRiatric inpatients on hospital visits after dischargE (ASPIRE): Protocol for a randomized controlled trial.
    Hias J; Hellemans L; Laenen A; Walgraeve K; Liesenborghs A; De Geest S; Luyten J; Spriet I; Flamaing J; Van der Linden L; Tournoy J
    Contemp Clin Trials; 2022 Aug; 119():106853. PubMed ID: 35842106
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A stepped wedge trial of efficacy and scalability of a virtual clinical pharmacy service (VCPS) in rural and remote NSW health facilities.
    Allan J; Nott S; Chambers B; Hawthorn G; Munro A; Doran C; Oldmeadow C; Coleman C; Saksena T
    BMC Health Serv Res; 2020 May; 20(1):373. PubMed ID: 32366308
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of a pharmacist collaborative drug therapy management protocol on utilization of a discharge prescription program and hospital readmissions.
    Rafferty JL; Mills KD; Morano M; Pogodzinski J; Chilbert MR; Clark CM
    Am J Health Syst Pharm; 2023 Aug; 80(16):1056-1062. PubMed ID: 37061822
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.